We improve existing drug products through the 505(j) or 505(b)(2) pathway, enabling quicker and more cost-effective approvals by utilizing FDA’s finding for safety and efficacy of the drugs. Our goal is to innovate drug products that helps increasing patient adherence, avoid incomplete dosing, eliminate dosing errors, improve product shelf-life and